7 Current news of oncomethylome
rssOncoMethylome's Technology to Be Used in Merck's Clinical Trial Program with Cilengitide
06-11-2008
OncoMethylome Sciences announced that it has signed a licensing and testing agreement with Merck KGaA of Darmstadt, Germany. Under the terms of the agreement, OncoMethylome will provide MGMT gene promoter methylation testing services for Merck's clinical trial program of cilengitide. As part ...
03-31-2008
OncoMethylome Sciences and Laboratory Corporation of America® Holdings (LabCorp®) announced that OncoMethylome has granted LabCorp an exclusive license on certain IP technology to perform commercial MGMT methylation laboratory testing services in the United States and Canada subject to ...
03-14-2008
OncoMethylome Sciences announced that its research collaborators demonstrated that gene methylation is significantly associated with recurrence of early stage non-small-cell lung cancer (NSCLC). Researchers from Johns Hopkins University (JHU) and Lovelace Respiratory Research Institute ...
12-18-2007
OncoMethylome Sciences entered into a pharmacogenomic service collaboration with Abbott. Under the terms of the collaboration, OncoMethylome will assist Abbott in profiling tumors. Specifically, OncoMethylome will be testing its DNA methylation biomarkers on Abbott's biological samples. "We ...
11-20-2007
OncoMethylome Sciences announced positive clinical results from its colorectal cancer screening program. Interim data from clinical trials demonstrated promising performance characteristics for OncoMethylome's blood-based colorectal cancer screening test. The new clinical trial data, which ...
Colorectal Cancer Screening Program and Service Testing Capabilities Strengthened
03-09-2007
OncoMethylome Sciences announced that it has significantly expanded its Amsterdam laboratory operations. The expansion involved hiring of 10 additional scientists experienced in the field of molecular diagnostics, purchase of necessary molecular laboratory equipment, obtaining ISO laboratory ...
10-26-2006
OncoMethylome Sciences announced that it has entered into a new non-exclusive service agreement with Schering-Plough. Under the terms of the new agreement, OncoMethylome will receive processing fees for providing Schering-Plough with testing services in connection with clinical trials focused ...
